MNKD Stock Summary and Trading Ideas (Mannkind | NASDAQ:MNKD)

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Mannkind trades on the NASDAQ stock market under the symbol MNKD.

As of September 2, 2026, MNKD stock price climbed to $4.04 with 2,449,498 million shares trading.

MNKD has a beta of 2.65, meaning it tends to be more sensitive to market movements. MNKD has a correlation of 0.16 to the broad based SPY ETF.

MNKD has a market cap of $1.30 billion. This is considered a Small Cap stock.

Last quarter Mannkind reported $109 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $798,600 and missed earnings estimates by -$.02.

In the last 3 years, MNKD traded as high as $7.63 and as low as $2.23.

The top ETF exchange traded funds that MNKD belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

MNKD has underperformed the market in the last year with a price return of -29.6% while the SPY ETF gained +20.7%. However, in the short term, MNKD had mixed performance relative to the market. It has outperformed in the last 3 months, returning +17.8% vs +1.0% return in SPY. But in the last 2 weeks, MNKD shares have been beat by the market, returning -8.1% compared to an SPY return of -0.5%.

MNKD support price is $3.86 and resistance is $4.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MNKD shares will trade within this expected range on the day.